Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016 : Care for the asplenic patient in general practice
dc.rights.license | open | en_US |
dc.contributor.author | QUÉFFÉLEC, C. | |
dc.contributor.author | BILLET, L. | |
hal.structure.identifier | Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept] | |
hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
dc.contributor.author | DUFFAU, Pierre | |
hal.structure.identifier | Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept] | |
hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
dc.contributor.author | LAZARO, Estibaliz | |
dc.contributor.author | MACHELART, I. | |
dc.contributor.author | GREIB, C. | |
hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
dc.contributor.author | VIALLARD, Jean-Francois | |
hal.structure.identifier | Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept] | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | PELLEGRIN, Jean-Luc | |
hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
dc.contributor.author | RIVIERE, Etienne | |
dc.date.accessioned | 2021-02-12T15:33:43Z | |
dc.date.available | 2021-02-12T15:33:43Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1471-2296 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/26236 | |
dc.description.abstractEn | Background Guidelines that detail preventive measures against Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, and influenza are published annually in France to decrease the risk of severe infections in immunocompromised patients. We aimed at describing adherence to these guidelines by GPs in the management of their asplenic patients in France between 2013 and 2016. Method We conducted a multicenter retrospective study between January 2013 and December 2016 in three French hospitals: asplenic adults were identified and their GPs were questioned. A descriptive analysis was performed to identify the immunization coverage, type and length of antibiotic prophylaxis, number of infectious episodes, and education of patients. Results 103 patients were finally included in this study: only 57% were adequately vaccinated against Streptococcus pneumoniae or Neisseria meningitidis, 74% against Haemophilus influenzae type b, and 59% against influenza. Only 24% of patients received a combination of all four vaccinations. Two-thirds of patients received prophylactic antibiotics for at least 2 years. Overall, this study found that 50% of splenectomized patients experienced at least one pulmonary or otorhinolaryngological infection, or contracted influenza. Conclusions These data match those reported in other countries, including Australia and the United Kingdom, meaning a still insufficient coverage of preventive measures in asplenic patients. Improved medical data sharing strategies between healthcare professionals, along with educational measures to keep patients and physicians up to date in the prevention of infections after splenectomy would improve health outcomes of asplenic patients. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | MORPH3EUS | |
dc.title.en | Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016 : Care for the asplenic patient in general practice | |
dc.title.alternative | BMC Fam Pract | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1186/s12875-020-01237-3 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 32787857 | en_US |
bordeaux.journal | BMC Family Practice | en_US |
bordeaux.page | 163 | en_US |
bordeaux.volume | 21 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.issue | 1 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | MORPH3EUS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-03140259 | |
hal.version | 1 | |
hal.date.transferred | 2021-02-12T15:33:47Z | |
hal.export | true | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMC%20Family%20Practice&rft.date=2020&rft.volume=21&rft.issue=1&rft.spage=163&rft.epage=163&rft.eissn=1471-2296&rft.issn=1471-2296&rft.au=QU%C3%89FF%C3%89LEC,%20C.&BILLET,%20L.&DUFFAU,%20Pierre&LAZARO,%20Estibaliz&MACHELART,%20I.&rft.genre=article |